Canada markets open in 5 hours 43 minutes

ImmunoGen, Inc. (IMU.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.8190-0.3090 (-6.03%)
As of 08:03AM CET. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.30B
Enterprise Value 1.10B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.57
Price/Book (mrq)19.47
Enterprise Value/Revenue 8.63
Enterprise Value/EBITDA -21.20

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3-17.26%
S&P500 52-Week Change 318.00%
52 Week High 39.1880
52 Week Low 34.1570
50-Day Moving Average 35.7355
200-Day Moving Average 35.3450

Share Statistics

Avg Vol (3 month) 3232
Avg Vol (10 day) 3310
Shares Outstanding 5220.11M
Implied Shares Outstanding 6N/A
Float 8171.11M
% Held by Insiders 10.41%
% Held by Institutions 183.52%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec. 31, 2020
Most Recent Quarter (mrq)Sep. 30, 2021

Profitability

Profit Margin -55.41%
Operating Margin (ttm)-42.33%

Management Effectiveness

Return on Assets (ttm)-12.40%
Return on Equity (ttm)-413.68%

Income Statement

Revenue (ttm)127.66M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)-49.40%
Gross Profit (ttm)17.71M
EBITDA -51.95M
Net Income Avi to Common (ttm)-70.74M
Diluted EPS (ttm)-0.3160
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)245.76M
Total Cash Per Share (mrq)1.21
Total Debt (mrq)19.4M
Total Debt/Equity (mrq)25.17
Current Ratio (mrq)2.42
Book Value Per Share (mrq)0.38

Cash Flow Statement

Operating Cash Flow (ttm)-115.01M
Levered Free Cash Flow (ttm)-8.53M